Shifting Attitudes on Pre-Planned Death Raises New Questions for Clinicians

Newswise — September 13, 2017 – Amid changing attitudes toward death and dying, some people with serious physical and/or mental illnesses are claiming a right to choose the time, place, and manner of their death. Discussions about "pre-planned death" pose new challenges for psychiatrists and other healthcare professionals to consider, according to an article in the September Journal of Psychiatric Practice, published by Wolters Kluwer.

As the concepts of assisted suicide and the 'right to die' become more accepted in society, "There's a growing likelihood that clinicians will encounter situations involving "pre-planned death by decisionally competent individuals," writes guest columnist Joel Yager, MD, of University of Colorado School of Medicine, Denver. His article seeks "to question conventional attitudes and assumptions, push readers' thoughts beyond typical comfort zones, and consider alternative modes of responding to challenges posed by pre-planned death."

Pre-Planned Death Raises Complex Personal and Professional Issues

Prompted by personal experiences and the recent passage of Colorado's "death with dignity" law, Dr. Yager reviews the shifting landscape related to pre-planned death—defined as "any death in which a decisionally capable individual takes actions to assure the end of life at a specified time, under specified circumstances, and via a specified mode of death."

Dr. Yager notes that the term pre-planned death is "neutral" as to whether the person has a "terminal, static, or progressive" medical or psychiatric illness, or whether the lethal act is administered by themselves or someone else. His discussion is limited to "decisionally capable" individuals—specifically excluding those whose wish to die results from symptoms of a treatable psychiatric illness.

Most people agree as to what constitutes a "good death," but don't get to choose the way they die. By a large majority, doctors say they would not want drastic measures to prolong life. When patients voice concerns about prolonged suffering at the end of life, Dr. Yager asks, "Shouldn't they be accorded the same dignities and care that physicians would want for themselves?"

He outlines the complex issues and terminology surrounding pre-planned death. In "physician-assisted" suicide, doctors may administer or supply to means to cause death. In pre-planned death, they may simply acknowledge the patient's intentions without interfering. "Theoretically, clinicians can accompany, witness, and be with patients as they go through actions that will lead to death," Dr. Yager writes.

He invites clinicians to think about a range of scenarios in which patients with serious medical and/or psychiatric illnesses may make a considered decision to plan their own deaths. Five states and the District of Columbia now have some type of "death with dignity" law, as do Canada and many European countries. While most discussions of these laws have focused on physician-assisted deaths, similar concerns might apply to "patient-initiated, self-conducted" deaths.

Although psychiatrists support medically assisted death in general, "they do not support such programs for psychiatric patients," according to Dr. Yager. He notes that the American Psychiatric Association has issued an opinion that psychiatrists "should not prescribe or administer any intervention to a non-terminally ill person for the purpose of causing death.”

"But ambiguity remains," Dr. Yager writes. "Does providing moral support for a patient or family under such circumstances constitute an intervention contributing to 'the purpose of death?'" Meanwhile, people suffering from physical or mental illnesses can find several movements and organizations providing information and assistance to people considering pre-planned death.

"Considerations regarding pre-planned deaths merit greater professional and public discussion," Dr. Yager concludes. "Many options exist for improving how professionals address the quality of human experiences surrounding death."

Click here to read the article: Contending With Preplanned Death: Questions for Clinicians

Article DOI: 10.1097/PRA.0000000000000260

###

About Journal of Psychiatric Practice

Journal of Psychiatric Practice®, a peer reviewed journal, publishes reports on new research, clinically applicable reviews, articles on treatment advances, and case studies, with the goal of providing practical and informative guidance for clinicians. Mental health professionals will want access to this journal­—for sharpening their clinical skills, discovering the best in treatment, and navigating this rapidly changing field. John M. Oldham, MD, is the editor in chief and past president of the American Psychiatric Association.

About Wolters Kluwer

Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.

Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.

Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and the organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

For more information about Wolters Kluwer’s solutions and organization, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.